vs
Side-by-side financial comparison of Cellectis S.A. (CLLS) and Home Federal Bancorp, Inc. of Louisiana (HFBL). Click either name above to swap in a different company.
Cellectis S.A. is the larger business by last-quarter revenue ($9.5M vs $6.0M, roughly 1.6× Home Federal Bancorp, Inc. of Louisiana). Home Federal Bancorp, Inc. of Louisiana runs the higher net margin — 27.8% vs -265.9%, a 293.7% gap on every dollar of revenue. On growth, Cellectis S.A. posted the faster year-over-year revenue change (375.0% vs 18.2%).
Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina.
Home Federal Bancorp, Inc. of Louisiana is a U.S. bank holding company based in Louisiana. It operates community banking services via its subsidiary, offering retail customers and local small businesses a full suite of financial products including deposit accounts, consumer loans, mortgage loans, and commercial financing, primarily serving local markets across Louisiana.
CLLS vs HFBL — Head-to-Head
Income Statement — Q2 FY2024 vs Q2 FY2026
| Metric | ||
|---|---|---|
| Revenue | $9.5M | $6.0M |
| Net Profit | $-25.3M | $1.7M |
| Gross Margin | — | — |
| Operating Margin | -181.1% | 35.1% |
| Net Margin | -265.9% | 27.8% |
| Revenue YoY | 375.0% | 18.2% |
| Net Profit YoY | -51.9% | 64.2% |
| EPS (diluted) | $-0.28 | $0.54 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $6.0M | ||
| Q3 25 | — | $5.9M | ||
| Q2 25 | — | $5.6M | ||
| Q1 25 | — | $5.2M | ||
| Q4 24 | — | $5.1M | ||
| Q3 24 | — | $4.7M | ||
| Q2 24 | $9.5M | $4.9M | ||
| Q1 24 | — | $4.9M |
| Q4 25 | — | $1.7M | ||
| Q3 25 | — | $1.6M | ||
| Q2 25 | — | $1.2M | ||
| Q1 25 | — | $748.0K | ||
| Q4 24 | — | $1.0M | ||
| Q3 24 | — | $941.0K | ||
| Q2 24 | $-25.3M | $638.0K | ||
| Q1 24 | — | $732.0K |
| Q4 25 | — | 35.1% | ||
| Q3 25 | — | 34.1% | ||
| Q2 25 | — | 27.5% | ||
| Q1 25 | — | 18.3% | ||
| Q4 24 | — | 23.7% | ||
| Q3 24 | — | 19.9% | ||
| Q2 24 | -181.1% | 16.9% | ||
| Q1 24 | — | 18.5% |
| Q4 25 | — | 27.8% | ||
| Q3 25 | — | 27.1% | ||
| Q2 25 | — | 20.9% | ||
| Q1 25 | — | 14.4% | ||
| Q4 24 | — | 20.0% | ||
| Q3 24 | — | 19.9% | ||
| Q2 24 | -265.9% | 13.1% | ||
| Q1 24 | — | 14.9% |
| Q4 25 | — | $0.54 | ||
| Q3 25 | — | $0.52 | ||
| Q2 25 | — | $0.38 | ||
| Q1 25 | — | $0.24 | ||
| Q4 24 | — | $0.33 | ||
| Q3 24 | — | $0.31 | ||
| Q2 24 | $-0.28 | $0.21 | ||
| Q1 24 | — | $0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $149.0M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $148.6M | $57.7M |
| Total Assets | $407.1M | $621.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $149.0M | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $57.7M | ||
| Q3 25 | — | $56.6M | ||
| Q2 25 | — | $55.2M | ||
| Q1 25 | — | $54.7M | ||
| Q4 24 | — | $53.9M | ||
| Q3 24 | — | $54.3M | ||
| Q2 24 | $148.6M | $52.8M | ||
| Q1 24 | — | $52.5M |
| Q4 25 | — | $621.4M | ||
| Q3 25 | — | $622.6M | ||
| Q2 25 | — | $609.5M | ||
| Q1 25 | — | $619.6M | ||
| Q4 24 | — | $607.8M | ||
| Q3 24 | — | $628.4M | ||
| Q2 24 | $407.1M | $637.5M | ||
| Q1 24 | — | $643.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $28.9M | $2.9M |
| Free Cash FlowOCF − Capex | $27.6M | — |
| FCF MarginFCF / Revenue | 290.5% | — |
| Capex IntensityCapex / Revenue | 13.2% | — |
| Cash ConversionOCF / Net Profit | — | 1.70× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $2.9M | ||
| Q3 25 | — | $2.8M | ||
| Q2 25 | — | $5.5M | ||
| Q1 25 | — | $991.0K | ||
| Q4 24 | — | $2.6M | ||
| Q3 24 | — | $871.0K | ||
| Q2 24 | $28.9M | $2.3M | ||
| Q1 24 | — | $650.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $843.0K | ||
| Q2 24 | $27.6M | $2.3M | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 17.8% | ||
| Q2 24 | 290.5% | 46.8% | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.6% | ||
| Q2 24 | 13.2% | 0.8% | ||
| Q1 24 | — | — |
| Q4 25 | — | 1.70× | ||
| Q3 25 | — | 1.74× | ||
| Q2 25 | — | 4.64× | ||
| Q1 25 | — | 1.32× | ||
| Q4 24 | — | 2.54× | ||
| Q3 24 | — | 0.93× | ||
| Q2 24 | — | 3.63× | ||
| Q1 24 | — | 0.89× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.